← Open Payments lookup

MICHAEL TOMCZYK: Open Payments

NPI 1871244723 · BRISTOL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,212 in 27 payments from 9 companies in 2025. Trend: 2023 $2,002 · 2024 $323 · 2025 $1,212

Food & beverage: $1,212
CompanyPaymentsAmount
Boston Scientific Corporation14$500
Amgen Inc.1$122
Novo Nordisk Inc1$121
AstraZeneca Pharmaceuticals LP1$114
Boehringer Ingelheim Pharmaceuticals, Inc.1$104
PFIZER INC.1$101
Novartis Pharmaceuticals Corporation4$81
E.R. Squibb & Sons, L.L.C.3$53
SCPHARMACEUTICALS INC.1$16

Products named: WATCHMAN FLX, REPATHA, Ozempic, FARXIGA, JARDIANCE, VYNDAQEL, LEQVIO, CAMZYOS.

Industry payments across CT — which companies pay providers there.